市場調查報告書
商品編碼
989335

全球注射器填充劑市場:增長,趨勢,COVID-19影響,預測(2021-2026)

Syringe Filling Machine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

在預測期2021-2026年,注射器填充機市場預計將以9%的複合年增長率增長。越來越多地採用各種腸胃外劑型的注射器和其他即用型(RTU)組件,有望促進注射器填充機市場的增長。

  • 近年來,由於對患者安全性,改進的工作條件和降低的製造成本的需求不斷增長,製藥行業對預填充注射器的需求增加了。隨著市場上一些新的發展,With Hikma Pharmaceuticals是2019年9月在美國推出新的預填充注射器功能的最新案例。該公司以預裝注射器的形式提供5,000單位/毫升的USP肝素鈉注射液。
  • 此外,治療需要連續接種疫苗的慢性疾病的需求不斷增長,預計將在預計的時間內促進採用注射器灌裝機。
  • 根據一項有關有關在歐盟/歐洲經濟區具有多種危險因素的主要人群中乙型和丙型肝炎的流行和發病率的歐洲監視文章,據估計,每人中有7110萬人患有乙型肝炎病毒。我被慢性感染(HBV)和丙型肝炎病毒(HCV)。在這種情況下,疫苗以預裝注射器的形式提供,因此,增加消費量有望促進市場增長。
  • 2019年2月,BD推出了BD Hylok TM。這是一種新型玻璃預灌裝注射器,用於注射粘性溶液,例如透明質酸皮膚填充劑。它以1毫升長的格式提供,將來還會推出更多尺寸,並附帶廣泛的數據包以支持產品或製藥公司的開發,技術和註冊工作。

本報告調查了注射器填充機的全球市場,概述了市場,分析了市場增長和障礙,市場機會,市場規模趨勢以及按類型和地區,競爭狀況,主要因素進行的預測,並提供了系統的信息例如公司資料。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第4章市場動態

  • 市場概況
  • 市場驅動因素和製約因素簡介
  • 市場驅動力
    • 越來越需要更新常規填充方法
    • 對預充式註射器的需求不斷增加
  • 市場限制
    • 高昂的安裝成本
  • 產業價值鏈分析
  • 波特的五種力量分析

第5章市場細分

  • 按類型
    • 自動化
    • 半自動
    • 手冊
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美洲
    • 中東和非洲

第6章競爭情況

  • 公司簡介
    • Maquinaria Industrial Dara, Sl
    • Vanrx Pharmasystems Inc.
    • Nordson Corporation
    • Musashi Engineering, Inc.
    • IMA Industria Macchine Automatiche SPA
    • Romaco Group
    • Added Pharma BV
    • Automated Systems of Tacoma (AST)
    • Shenzhen Penglai Industrial Corporation Limited.
    • OPTIMA packaging group GmbH
    • Prosys Innovative Packaging Equipment

第7章 投資分析

第8章 市場機會與動向

目錄
Product Code: 67686

The syringe filling machine market is expected to register a CAGR of 9% during the forecast period (2021 - 2026). The increasing adoption of the syringes and other ready-to-use (RTU) components for a variety of parenteral dosage forms is expected to boost the growth of the syringe filling machine market.

Key Highlights

  • In recent years there has been a growing demand for prefilled syringes as there has been an increased need for patient safety, improved working conditions, and reduced cost of production in the pharmaceutical industry. The market has seen several new developments and With Hikma Pharmaceuticals being the latest to launch a new prefilled syringe capability in the United States in September 2019. The company would be supplying heparin sodium injection, USP, 5000 units/mL in prefilled syringe form.
  • Also, the growing demand to treat chronic diseases that require continuous vaccination is expected to boost the adoption of the syringe filling machines over the forecast period.
  • According to Eurosurveillance's article on Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU/ EEA, an estimated 71.1 million people are chronically infected with the hepatitis B virus (HBV) and hepatitis C virus (HCV), respectively. As the vaccines for such cases are available in pre-filled syringes form, its increased consumption is expected to boost the market growth.
  • In February 2019 - BD launched BD HylokTM, its new glass pre-fillable syringe for the administration of viscous solutions such as hyaluronic acid dermal fillers available in 1ml long format, with additional sizes to be introduced in the future, and comes with an extensive data package to support product or drug manufacturers developmental, technical and registration efforts..

Key Market Trends

Increased Shelf Life and Reduction Of Wastage

  • It is estimated that the medication stored inside of a prefilled syringe cartridge will remain sterile for approximately two to three years when compared to a standard syringe which can be sterile for only 12 hours when filled. Also, the prefilled syringes have lesser overfill when compared to manual filling. It is estimated that for a 0.5 ml vial, the USP recommends 20-25% overfill. In contrast, for 0.5 ml, the required overfills are less than 2%. As a result, potentially 18-23% more doses can be produced.
  • Also, With the increasing technological disruptions taking place across industries, owing to the wide-adoption of Industry 4.0 and automation amongst others, the pharmaceutical industry is adopting new and effective methods of drug creation. Pharmaceutical syringe filling equipment allows companies to streamline the syringe packing process as these are capable of filling up to hundreds of syringes per minute.
  • The pharmaceutical syringe filling equipment maintains longer sterility and provides precise, automated control over barriers, tips, and additional accessories required for syringes. Moreover, the manufacturers can bring the the overal cost down with the help of high output pharmaceutical syringe filling machines.
  • In March 2019, the pharmaceutical packaging company Schott Kaisha expanded its capacity to manufacture vials, pre-filled syringes, and sterile solutions. The company's expansion plans include new sites in Gujarat and North India, along with the expansion and up-gradation of existing plants in Daman and Jambusar in Gujarat. These developments are expected to augment the market growth in the emerging economies as the pharmaceutical companies start adopting these machines for their drug creation.
  • The market is witnessing a rising need for infused product manufacturers for sufficient filling machinery for CBD and THC products. The CBD oil cartridges require filling equipment that can provide detailed parts, and simple changeover, and cleanup, quick turnaround, among other factors, due to which pharmaceutical companies have been more inclined towards syringe filling machine for CBD applications.
  • In February 2019, Optima Pharma introduced its MultiUse filler machine designed to process different types of containers in a flexible and fully automated way. Optima's MultiUse Filler fills vials, syringes, and cartridges with one machine and allows for small batch sizes and different container types. These initiatives by various pharmaceutical companies will further stimulate market growth.

North America is Expected to Hold Significant Share

  • The CDC, FDA, and NASEN are the main regulatory bodies in the North American region. These regulatory bodies have been increasingly promoting the safety of the patients that are administered with vaccines. The prefilled syringes are going to play an important role in the administration of the vaccine in the US as there are rising concerns about the overdose of vaccines administered to children.
  • Furthermore, this region has seen significant developments in the syringe filling machines, most recently NC-based Mission Health in Asheville, installed two RIV automated IV compounding systems from ARxIUM that sterile-fill liquids and lyophilized products into IV syringes, and bags for administration to Mission Health patients.
  • Also, The increasing number of chronic diseases in the region that require frequent vaccine usage is one of the prominent factors contributing to the growth of the market over the forecast period. According to the hepatitis B foundation, Up to 80,000 Americans will become newly infected with Hepatitis B each year, and more than 2 million Americans are chronically infected. More and more manufacturers in this region are getting approval for prefilled syringes for Hepatitis B vaccines. Dynavax was one of the major pharma company to receive FDA approval for their pre-filled syringe vaccine HEPLISAV-B in March 2018.
  • The technological advancements in the region in terms of robotics is one of the prominent factors that would drive the growth of the syringe filling machine in the region. For instance, FP Developments that provide syringe filling and handling, vial filling and handling, mark and verify, track-and-trace, unique device identification (UDI) uses a Universal Robots UR-3 robotic arm to perform aseptic syringe filling and capping.

Competitive Landscape

The market is highly fragmented with the presence of some key players such as Nordson Corporation, Romaco Group, and many smaller players. Innovation and cost have been a crucial factor for the companies operating in this market.

  • April 2019 - Pharmaceutics International, Inc. (Pii), a Contract Development and Manufacturing Organization (CDMO) and Automated Systems of Tacoma, LLC (AST), a provider of flexible aseptic filling systems, announce their partnership on the new GENiSYS R filling machine for syringes, cartridges, and vials. GENiSYS R's adaptive approach uses flexible robotic automation to process ready-to-fill vials, syringes, and cartridges on the same machine. Both peristaltic and rotary piston dispensing systems are available to accurately fill each container directly on an electronic balance to provide up to 100% in-process fill weight inspection.
  • December 2019 - Steriline, launched its robotic nest filling machine, the new machine is a compact filling machine specifically designed to be used in laboratories.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Introduction to Market Drivers and Restraints
  • 4.3 Market Drivers
    • 4.3.1 The Rising Need to Replace the Conventional Filling Method
    • 4.3.2 The Rising Demand For the Prefilled Syringes
  • 4.4 Market Restraints
    • 4.4.1 High installation Cost
  • 4.5 Industry Value Chain Analysis
  • 4.6 Industry Attractiveness - Porter's Five Force Analysis
    • 4.6.1 Threat of New Entrants
    • 4.6.2 Bargaining Power of Buyers/Consumers
    • 4.6.3 Bargaining Power of Suppliers
    • 4.6.4 Threat of Substitute Products
    • 4.6.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Automated
    • 5.1.2 Semi-Automated
    • 5.1.3 Manual
  • 5.2 Geography
    • 5.2.1 North America
    • 5.2.2 Europe
    • 5.2.3 Asia Pacific
    • 5.2.4 South America
    • 5.2.5 Middle East and Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Maquinaria Industrial Dara, Sl
    • 6.1.2 Vanrx Pharmasystems Inc.
    • 6.1.3 Nordson Corporation
    • 6.1.4 Musashi Engineering, Inc.
    • 6.1.5 I.M.A. Industria Macchine Automatiche S.P.A.
    • 6.1.6 Romaco Group
    • 6.1.7 Added Pharma B.V.
    • 6.1.8 Automated Systems of Tacoma (AST)
    • 6.1.9 Shenzhen Penglai Industrial Corporation Limited.
    • 6.1.10 OPTIMA packaging group GmbH
    • 6.1.11 Prosys Innovative Packaging Equipment

7 INVESTMENT ANALYSIS

8 MARKET OPPORTUNITIES AND FUTURE TRENDS